S.D. Codified Laws § 34-20B-17

Current with legislation signed by the governor on or before 3/6/2024

Section 34-20B-17 - Opiates included in Schedule II

Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule II, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

(1) Alphaprodine;

(2) Anileridine;

(3) Bezitramide;

(4) Diphenoxylate;

(5) Fentanyl;

(6) Isomethadone;

(7) Levomethorphan;

(8) Levorphanol;

(9) Metazocine;

(10) Methadone;

(11) Methadone-intermediate, 4-cyano-2-dimethylamine-1, 4-diphenyl butane;

(12) Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;

(13) Pethidine;

(14) Pethidine-intermediate, A, 4-cyano-1-methyl-4-phenylpiperidine;

(15) Pethidine-intermediate, B, ethyl-4-phenylpiperidine-4-carboxylate;

(16) Pethidine-intermediate, C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;

(17) Phenazocine;

(18) Piminodine;

(19) Racemethorphan;

(20) Racemorphan;

(21) Sufentanil;

(22) Alfentanil;

(23) Carfentanil;

(24) Levo-alphacetylmethadol, also known as levo-alpha-acetylmethadyl acetate or LAAM;

(25) Remifentanil;

(26) Oxymorphone;

(27) Oripavine (3-O-demethylthebaine or 6,7,8,14-tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol);

(28) 4-anilino-N-phenethylpiperidine (ANPP);

(29) Morphine, except when it meets subdivision 34-20B-23(8);

(30) Hydrocodone (Dihydrocodeinone);

(31) Codeine, except when it meets subdivision 34-20B-23(1), 34-20B-23(2), or 34-20B-26(1);

(32) Dihydrocodeine, except when it meets subdivision 34-20B-23(5) or 34-20B-26(2);

(33) Ethylmorphine, except when it meets subdivision 34-20B-23(6) or 34-20B-26(3);

(34) Oxycodone;

(35) Hydromorphone;

(36) Thiafentanil;

(37) Noroxymorphone;

(38) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl); and

(39) Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate).

SDCL 34-20B-17

SL 1970, ch 229, § 8 (b) (1); SDCL Supp, § 39-17-60; SL 1985, ch 278, § 52; SL 1987, ch 255, § 4; SL 1989, ch 293, § 3; SL 1994, ch 278, § 3; SL 2002, ch 167, §1; SL 2007, ch 194, §1, eff. Feb. 1, 2007; SL 2008, ch 170, §2, eff. Feb. 13, 2008; SL 2011, ch 160, §2, eff. Feb. 24, 2011; SL 2015, ch 180, §3, eff. Feb. 18, 2015; SL 2017, ch 156, §2, eff. Feb. 3, 2017; SL 2020, ch 144, §2, eff. Mar. 9, 2020; SL 2021, ch 144, §5, eff. Feb. 17, 2021.

Amended by S.L. 2021, ch. 144,s. 5, eff. 2/17/2021.

Amended by S.L. 2020, ch. 144,s. 2, eff. 3/9/2020.

Amended by S.L. 2017, ch. 156,s. 2, eff. 2/3/2017.

Amended by S.L. 2015, ch. 180,s. 3, eff. 2/18/2015.